Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider

Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider

Background: Erythrodermic cutaneous T-cell lymphoma (E-CTCL) is associated with a poor prognosis and severe symptoms. Objective: To establish insights into the quality of life (QoL), expectations, and treatment satisfaction of E-CTCL patients receiving mogamulizumab. Methods: Outcomes of this prospe...

Full description

Bibliographic Details
Main Authors: Rosanne Ottevanger, Sylvia van Beugen, Andrea W. M. Evers, Rein Willemze, Maarten H. Vermeer, Koen D. Quint
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
cutaneous T-cell lymphoma
quality of life
mogamulizumab
mycosis fungoides
Sézary syndrome
treatment expectations
Online Access:https://www.mdpi.com/2072-6694/15/1/32

Internet

https://www.mdpi.com/2072-6694/15/1/32

Similar Items